Century Therapeutics IPSC
NASDAQ IPSC
$2.11 +0.02 (+0.96%)
At close: Sep 4, 2026 · 4:00 PM EDT

Century Therapeutics (IPSC) Revenue (QoQ) (2022 - 2025)

Analysis

Century Therapeutics (IPSC) Revenue (QoQ) (2022 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Century Therapeutics 440.37 Mn 180.29 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 2,515.96%
Dec 31, 2024 427.56%
Sep 30, 2024 2.59%
Jun 30, 2024 -9.82%
Mar 31, 2024 219.03%
Dec 31, 2023 81.08%
Sep 30, 2023 49.49%
Jun 30, 2023 -94.24%
Mar 31, 2023 230.13%
Dec 31, 2022 -76.57%
Sep 30, 2022 59.31%
Jun 30, 2022 31.95%